Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
Reading the discussion between Daringinvesror & Ananda, I tend to side with Ananda, the company have stated that they were in advanced negotiations with several Pharma , that indicates that Futura have a figure in mind which wasn’t met last year. We have moved on from then with further positive data on the safety safety. They have already bought CSD to market and having had their fingers burnt with that they are not going to make the same mistake twice.
There is a real bullish attitude being expressed regarding the results of this phase 3 trial from the company , suggestions have been that Pharma required more info , probably regarding the safety. Don’t tell me that if a major player comes in with a knockout offer for the product Futura are going to decline it. This is going far north of where it stands at present, the only thing holding it back now is Lombard supplying the market. That will end over the next few weeks.
StarRage, suggested being the operative word, Futura have moved down the line with with safety of the product, this is going to be big and if a Pharma thinks likewise they will not hang about. A deal could come at any point in time.
Thomas , I wouldn’t bother yourself worrying about how Lombard are disposing of their shares, they are going to continue doing what suits them.
What interests me more is how Lombard read the market leading up to the 7p dilution and managed to offload a large number of shares leading up to the announcement at a big premium to the 7p mark and then were able to buy the large quantatiy thet they have at 7p.
These are now also being disposed of at well above a 100% profit. All this knowledge they have especially when long term holders have been holding shares that they have paid 10 Xs the price they picked them up in the dilution.
Are they just clever boys?
Daring, you must be an author , why did you stop? I was on the edge of my seat! Anyway guys if I was you I wouldn’t give a toss about the delayed RNS, over 2 million more shares sold than bought this week and that is with Lombard supplying the market. I don’t believe that can last much longer , but only they know the answer to that. I personally believe investors have been duped into selling yesterday. I topped up in yesterday pm as I was busy during the morning, but it dropped into the 16p mark, what a steal. This week with the presentation I believe the share price will take off again and then we have I think Slovenia to come. Angela is right , the late RNS will be long in the memory after the next couple of weeks and then we start the few month build up to TPR. Lombard I believe will call a halt to selling at a point only they know but when this happens where are the shares to feed the market going to come from? There will be a continuing appetite to feed investors demands for more shares , this will lead to the inevitable price rise.someone posted that we would see 50p prior to results of phase 3 but when you read Darin’s little story I am now thinking well north of that. AIMO
I am a past share holder of a four year term, got out at £5.20 six weeks prior to its first major foreign deal having made 25% on my original stake. Felt pig sick but was pleased for all other long term holders. I have to say how brilliant are the boys who have set this up , I never thought they would get it to this level and believed hool more than I did Rocka. Anyway this fire is I believe going to have a major effect on the company, in the middle of building all the hubs around the world and in potential discussions with both Marks & Waitrose plus others. With earnings dropping in this last financial statement this is certainly not what the company needs , if I was still holding I would out like a flash, but I have been wrong before and although I believe this is going to cost the company big in more ways than one in the medium term , I will be looking at any weakness in the share price to buy back in. It is a changed market though for Ocado that’s for sure.
You have to wonder where the share price would be without Lombard feeding the market. At this rate I cannot see them continuing to supply the market , at that point what with presentations and news on our gels in general I cannot see this going in any other direction other north. Totally unexpected , I didn’t see this ramping up until April time but not complaining. I would not estimate either where this price is going to be prior to December results. Unbelievable until you actually think about the potential long term outcome with the company as a whole.
Rest assured , if this trial is a success as I expect it to be , Furtura have had their fingers burnt already with CSD. They will have learnt , I do not expect they will make the same mistakes again, Med will be highly sort after all around the world as it will be a blockbuster, common sense tells you that. Management know that and now have the knowledge needed to sign the right deal.
I agree the company is bullish about both the outcome of phase 3 and concluding a deal, they must have felt they were close last year when actually they were not in signing a deal for Med, Being bullish now is not going to get the company anywhere, if this trial fails I believe the company will fail with it, it is fully funded to the middle of next year and existing share holders will not be willing to bale it out any further. This is it, make or break, they have produced CSD a similar type of product and they must have a strong indication of how the Med gel is going to work. The results on the efficacy of this Med were highly likely to have been the reason a deal was not signed in 2018, i believe you can see it in Ken’s face during the latest interview, I have put a large percentage of my funds into Futura and I am not in the slightest bit worried! This is obviously AIMO but I truly believe you can almost read this as it is happening now.
KEN JAMES, Where have you been hiding? Please do all presentations from now on, clear , fast and very informative. The compare could not keep up with this buoyant discussion. Look forward to seeing Ken performing next month, all fantastic news for the company, de-risking the product even further. How cheap is this looking at where it stands today,I will be topping up that’s for sure!
One bonus of any further financial regulation on NG in the next round of negotiations will surely be a deterrent to any potential Corbyn government trying to renationalise the company. Just cannot see how they would justify the cost of utilities if the regulation cuts any profits of the companies in this fashion.
Rhodi , If you had bothered to bye a tank of fuel and gone to the agm you would know when they are funded too. Anyway get ready with your £100 K because 15p is on its way and we will all be watching for your buy which will push it up into the 16ps.
Bottom line Hawk and I don’t disagree with you on CSD , but once again management screwed up that as well, MED offers a totally different concept from what is available on the market. Quite simply who wants to prepare 30 minutes plus prior to performing when you can get it on in 5-10 minutes. Sex is a spontaneous emotion so if this gel comes through I can see nothing other than it being a complete blockbuster. Consequently I have invested with my pension, ISA and fund account so I’ve spoken with decent money in each, put my money where my mouth is. The company have stated that this is the most de-risked of all the products they have produced and results from previous trials backs this up. No doubt this is last chance saloon for Futura , but if comes off it will pay off BIG time!!! What ever the price will be and the answer to that none of us know , but one thing I will say is I am sure different pharma will want a piece of this pie and will pay good money for it.
So you feel CSD 2017 is in the same bracket as MED having passed phase 3 trials at the end of this year? Well I disagree with you there. I completely agree with you regarding how long term share holders have been shafted by incompetent management, so at least we agree on something. Anyway should be a good week ahead as I also agree a strong chance of breaking 15p and also interesting as Rhodi will then be back in with his £100k buy, Can’t wait!
GREAT RESEARCH BRAINS!!!!
So Hawky, Two years ago with the share price at 52p, you announce that it is time for the share price to advance. Yet now with a potential blockbuster in phase 3 trials you estimate it at just 30p if it passes. Ok we’ve had the dilution but the company is in a totally different place now. You talk about Rampers but you are saying exactly what suits you.
Brains once again , very good! Embarrassing for Hawkhead!